Trials / Completed
CompletedNCT06629987
Determining the Most Efficient Screening Cut Off Levels for Phenylketonuria (PKU)
Determining the Most Efficient Screening Cut Off Levels for Phenylketonuria (PKU) by Assessing Two Years of Screening with Tandem Mass Spectrometry (MS) : a French National Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 360 (actual)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 3 Days
- Healthy volunteers
- Not accepted
Summary
studying the screening of PKU in france with the new tandemMS
Detailed description
Nationwide cohort study of the new pku screening for patient beetwen 180 and 360 µmol/L.
Conditions
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2021-01-01
- Completion
- 2022-12-31
- First posted
- 2024-10-08
- Last updated
- 2024-10-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06629987. Inclusion in this directory is not an endorsement.